Latest News About Vitamin K

Here are the latest general developments on vitamin K, based on recent public reporting and health resources.

• Vitamin K signaling and cardiovascular health: Observational studies continue to explore links between higher vitamin K intake (from leafy greens and certain oils) and lower cardiovascular disease risk, though evidence is not yet definitive for causal effects or optimal intake levels. This remains an active area of research with ongoing trials and meta-analyses expected.[3]

• Newborn vitamin K recommendations and testing: Guidance around vitamin K administration at birth and the monitoring for deficiency bleeding in newborns remains a priority in neonatal care, with continued emphasis on ensuring timely prophylaxis and documenting outcomes in various countries.[1]

• Dietary sources and population intake: Public health communications continue to promote leafy greens (kale, spinach, broccoli) and certain vegetable oils as primary sources of vitamin K, highlighting potential interactions with anticoagulant medications and the importance of consistent intake for those on such therapies.[8][3]

• Global regulatory and supply updates: There are periodic regulatory notes and recalls related to vitamin K-containing products in the pharmaceutical supply chain, underscoring ongoing quality control in manufacturing and distribution of phytonadione formulations.[2]

• Research highlights from health journals: Reviews and research briefs summarize potential mechanisms by which vitamin K may influence vascular and bone health, though clinical recommendations typically stress a balanced diet rather than high-dose supplementation unless advised by a clinician.[3]

If you’d like, I can narrow this to: (a) clinical trial results from 2024–2026, (b) newborn vitamin K prophylaxis updates, or (c) dietary guidelines and food sources with recommended daily intakes. I can also pull up specific studies or summarize the Office of Dietary Supplements fact sheet for health professionals.